Frontiers in Immunology (May 2022)

Therapy Targets SARS-CoV-2 Infection-Induced Cell Death

  • Zhoujie Zhu,
  • Jiayi Shi,
  • Long Li,
  • Long Li,
  • Jinling Wang,
  • Yufen Zhao,
  • Yufen Zhao,
  • Huabin Ma,
  • Huabin Ma

DOI
https://doi.org/10.3389/fimmu.2022.870216
Journal volume & issue
Vol. 13

Abstract

Read online

Coronavirus Disease 2019 (COVID-19) caused by SARS-CoV-2 has become a global health issue. The clinical presentation of COVID-19 is highly variable, ranging from asymptomatic and mild disease to severe. However, the mechanisms for the high mortality induced by SARS-CoV-2 infection are still not well understood. Recent studies have indicated that the cytokine storm might play an essential role in the disease progression in patients with COVID-19, which is characterized by the uncontrolled release of cytokines and chemokines leading to acute respiratory distress syndrome (ARDS), multi-organ failure, and even death. Cell death, especially, inflammatory cell death, might be the initiation of a cytokine storm caused by SARS-CoV-2 infection. This review summarizes the forms of cell death caused by SARS-CoV-2 in vivo or in vitro and elaborates on the dedication of apoptosis, necroptosis, NETosis, pyroptosis of syncytia, and even SARS-CoV-2 E proteins forming channel induced cell death, providing insights into targets on the cell death pathway for the treatment of COVID-19.

Keywords